This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

SYMBIS Surgical System Named To 2014 Space Technology Hall Of Fame

Stocks in this article: IM IMRS

MRI-compatible robot leveraged from space program technology inspired by goal to improve neurosurgical precision and outcomes

MINNEAPOLIS, May 28, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the SYMBIS Surgical System - the second generation of the neuroArm® / SYMBIS™ program - is a 2014 inductee into the Space Technology Hall of Fame. The Space Foundation honor is directed at technologies originally developed for space exploration that are being transformed into products to help improve the quality of life on Earth.

(Photo: )

"As an element of the future of neurosurgery, SYMBIS involves developing more precise minimally-invasive techniques with motion refinement where surgeons can reach small and eloquent areas to remove diseased tissue, and cause no damage to the adjacent delicate structures to protect the patient's quality of life and maximize the success of the surgery," said Meir Dahan, IMRIS Chief Technology Officer and Executive Vice President of Research and Development.

The SYMBIS program originated in 2002 under the name neuroArm as a collaborative research concept primarily between the University of Calgary and MacDonald, Dettwiler and Associates (MDA) - the company which developed large robotic arms for the International Space Station and US space shuttle programs. Design work initially focused on developing haptic (touch sensing) control mechanisms, special motors, semi-automated surgical tool exchange protocols, and communications technologies. The intent was to pair near real-time, high-resolution magnetic resonance (MR) and anatomical images with robotic arm manipulation technologies to provide neurosurgeons with image guidance, precision, accuracy and dexterity.

"Where SYMBIS has come from and is heading to, represents collaborations of many interdisciplinary creative teams of engineers, scientists and surgeons. Our goal was to integrate the surgeon's skills and decision making with mechanized accuracy," said Dr. Garnette Sutherland, Professor of Neurosurgery at University of Calgary, who led the team which developed the original robot, neuroArm. "This honor and research illustrates how the merging of human surgical experience with machines and computerized technology is driving neurosurgical advancement towards more minimalism and finer accuracy."

The SYMBIS system now consists of two manipulator arms with eight degrees of freedom of movement on a mobile base and a remote workstation where a surgeon sits and is provided with a virtual environment that recreates the sight, sound and touch of surgery. The arms operate surgical tools only in conjunction with the surgeon's remote hand movements. (The SYMBIS Surgical System is not currently available for sale.)

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs